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INTRODUTION
METHODS
Heart transplantation is considered the gold standard treatment for selected patients with end-stage heart disease when medical therapy has been unable to halt progression of the underlying pathology. Scientific
evidence suggests that cardiac rehabilitation (CR), with a focus on exercise, can be effective in reversing the consequences of previous physical deconditioning, pathophysiological changes associated with cardiac
denervation and prevented adverse reactions induced by immunosuppression. Prescribing and evaluating interventions in the context of CR is a complex process, and the instruments to be used for measuring and
prescribing exercise are not always consensual. The 6-minute gait test (6MWT) has been used as a way of assessing functional capacity, clinical staging, cardiovascular prognosis and monitoring of the rehabilitation
program. Safety and metabolic impact are poorly described in the literature with regard to heart transplant recipients.
31 heart transplanted patients, 25 men and 6 women, with a mean age of 58.19 (9.57)
years and an average transplant time of 5.47 (4.40) years. They were submitted to
evaluation using the 6MWT, with electrocardiographic monitoring by telemetry and
with initial and final recording of heart rate, systolic and diastolic blood pressure. The
Modified Borg Scale was also applied before and after the 6MWT. Anthropometric
parameters were also recorded: height, weight and the body mass index was inferred.
The 6MWT was performed according to the guidelines of the American Thoracic
Society. To calculate the expected 6MWT distance (D6MWT) the equations define by
Enright & Sherrill to the health population was used:
♂: D6MWT = (7,57 x staturecm) – (5,02 x ageyears) – (1,76 x weightkg) – 309; r2 = 0,42
♀: D6MWT = (2,11 x staturecm) – (2,29 x weightkg) – (5,78 x ageyears) + 667; r2 = 0,38
Inclusion criteria: freely and voluntarily participate in the study, transplanted for
more than 3 months and without any clinical contraindication for participation in the
evaluations.
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Idade (anos)
Tempo de 
transplante (anos)
N 31 31
Média 58,19 5,47
Desvio Padrão 9,57 4,40
Mínimo 37 0,25
Máximo 79 13
Peso (Kg) Altura (cm) IMC
N 31 31 31
Média 78,46 169,00 27,37
Desvio Padrão 12,96 8,22 3,15
Mínimo 56 149 21,7
Máximo 116 187 33,5
Borg inicial Borg final
FC inicial 
(bat/min)
FC final 
(bat/min)
TA sis inicial 
(mm/Hg)
TA sis final 
(mm/Hg)
TA dias inicial 
(mm/Hg)
TA dias final 
(mm/Hg)
Fração de 
ejeção (%)
N 31 31 31 31 31 31 31 31 31
Média 0,39 1,77 83,03 86,32 130,19 133,90 77,48 79,23 69,32
Desvio Padrão 0,96 2,11 12,18 14,03 19,65 21,50 11,29 9,28 6,64
Mínimo 0 0 58 56 98 100 58 60 48
Máximo 4 7 108 110 178 205 96 95 82
p 0,000 0,007 0,111 0,442
TM6m avaliado (m) TM6m esperado (m)
Diferença entre TM6m 
esperado e avaliado (m)
N 31 31 31
Média 356,39 543,38 187,06
Desvio Padrão 92,57 69,49 94,10
Mínimo 140 407 0
Máximo 560 666 360
p 0,000
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